Mike Mirizzi

Mike Mirizzi has over 25 years of hands-on experience and technical management/leadership in medical device R&D and product development in start-up, medium and large companies spanning multiple clinical indications. Before joining Venclose, Mr. Mirizzi served as Director of R&D for Spirox/Entellus/Stryker where he was responsible for helping to build and direct the R&D team commercializing a novel bioabsorbable Nasal Implant for treating nasal airway obstruction. Over his career, Mr. Mirizzi has held multiple positions of increasing responsibility at Qool Therapeutics, Inc. as Vice President of R&D developing new therapies for therapeutic hypothermia, Director of R&D at VNUS/Covidien developing new therapies for multiple indications including venous insufficiency, Guidant Compass Neurovascular and Target Therapeutics developing endovascular technologies for treating ischemic stroke. He started his career at Alcon Surgical manufacturing and developing products for ophthalmic indications. Mr. Mirizzi holds a Bachelor of Science in Industrial Engineering from California Polytechnic State University, San Luis Obispo and is an inventor on over 70 issued and pending US and foreign patents.